Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02OTK
|
|||
Former ID |
DNCL001654
|
|||
Drug Name |
CH-4051
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
Company |
Chelsea Therapeutics
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H23N5O5
|
|||
Canonical SMILES |
C=C(CC(C(=O)O)NC(=O)C1=CC=C(C=C1)CCC2=CC3=C(C=C2)N=C(N=C3N)N)C(=O)O
|
|||
InChI |
1S/C23H23N5O5/c1-12(21(30)31)10-18(22(32)33)26-20(29)15-7-4-13(5-8-15)2-3-14-6-9-17-16(11-14)19(24)28-23(25)27-17/h4-9,11,18H,1-3,10H2,(H,26,29)(H,30,31)(H,32,33)(H4,24,25,27,28)/t18-/m0/s1
|
|||
InChIKey |
NAWXUBYGYWOOIX-SFHVURJKSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dihydrofolate reductase (DHFR) | Target Info | Inhibitor | [2] |
KEGG Pathway | One carbon pool by folate | |||
Folate biosynthesis | ||||
Metabolic pathways | ||||
Panther Pathway | Tetrahydrofolate biosynthesis | |||
Formyltetrahydroformate biosynthesis | ||||
Pathwhiz Pathway | Folate Metabolism | |||
Pterine Biosynthesis | ||||
Pathway Interaction Database | E2F transcription factor network | |||
Reactome | E2F mediated regulation of DNA replication | |||
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | ||||
Metabolism of folate and pterines | ||||
G1/S-Specific Transcription | ||||
WikiPathways | Nucleotide Metabolism | |||
Trans-sulfuration and one carbon metabolism | ||||
Retinoblastoma (RB) in Cancer | ||||
One Carbon Metabolism | ||||
Metabolism of water-soluble vitamins and cofactors | ||||
Metabolism of nitric oxide | ||||
Folate Metabolism | ||||
Fluoropyrimidine Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01116141) A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA). U.S. National Institutes of Health. | |||
REF 2 | CH-1504, a metabolically inert antifolate for the potential treatment of rheumatoid arthritis. IDrugs. 2010 Aug;13(8):559-67. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.